Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC
Daiki Ikarashi, Tamio Okimoto, Takehito Shukuya, et al.
JTO Clinical and Research Reports (2021) Vol. 2, Iss. 10, pp. 100230-100230
Open Access | Times Cited: 17

Showing 17 citing articles:

The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer
Jack Gudgeon, José Luis Marín‐Rubio, Matthias Trost
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 70
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
Yu-Chang Wang, Rui Chen, Yue Wa, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer
Jiexi Wen, Jie Zeng Yu, Catherine Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2044-2044
Open Access | Times Cited: 7
Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
Alejandro Ríos-Hoyo, Edurne Arriola
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma
David Restle, Joseph Dux, Xiaoyu Li, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006609-e006609
Open Access | Times Cited: 11
Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases
Markus Kleinberger, Didem Çifçi, Christina Paiato, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Genomic and Immune Landscape of Non–Small Cell Lung Cancer Brain Metastases
Manlu Liu, Justin C. Jagodinsky, S. Carson Callahan, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Altered CD4 T cell response in oligometatastic non-small cell lung cancer brain metastasis
Mais Alsousli, Cécile L. Maire, András Piffkó, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases
Ilana Schlam, Margaret E. Gatti‐Mays
The Oncologist (2022) Vol. 27, Iss. 7, pp. 538-547
Open Access | Times Cited: 15
High CD204+ tumor-associated macrophage density predicts a poor prognosis in patients with clear cell renal cell carcinoma
Yuxia Xie, Guping Tang, Ping Xie, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1511-1522
Open Access | Times Cited: 3
Boosting the Immune Response—Combining Local and Immune Therapy for Prostate Cancer Treatment
Jakub Karwacki, Aleksander Kiełbik, Wojciech Szlasa, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2793-2793
Open Access | Times Cited: 12
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection
David Wasilewski, Julia Onken, Paul Höricke, et al.
Journal of Neuro-Oncology (2024) Vol. 167, Iss. 1, pp. 155-167
Open Access | Times Cited: 1
Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration
Vered Fuchs, Ariel Sobarzo, Maha Msamra, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 9, pp. 2227-2239
Open Access | Times Cited: 1
Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments
Suzanne M. Castenmiller, Rosa de Groot, Aurélie Guislain, et al.
Immuno-Oncology Technology (2022) Vol. 15, pp. 100090-100090
Open Access | Times Cited: 3
Potential synergistic effects of cranial radiotherapy and atezolizumab in non-small cell lung cancer: an analysis of individual patient data from seven prospective trials
Tiantian Guo, Yue Zhou, Fei Liang, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 1, pp. 126-138
Open Access
Publications from Juntendo University Graduate School of Medicine, 2021 [5/6]
〈original Articles〉, Oda Okamoto, Izawa Kaitani, et al.
Juntendo Medical Journal (2024) Vol. 70, Iss. 1, pp. 65-85
Open Access
The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature
Eleni Eleftheriadou, Maria Saroglou, Nikolaos Syrigos, et al.
Monaldi Archives for Chest Disease (2024)
Open Access
BRAIN-METASTATIC MELANOMA MODELS UNCOVER IMMUNE AND MOLECULAR CORRELATES OF RESPONSE TO IMMUNOTHERAPY
Amélie Lopès, Eva Pérez‐Guijarro, Vishaka Gopalan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top